About Index Trending news
Analyze
Top 50 Pricing
Pulmatrix

Pulmatrix

Work at Pulmatrix? Add yourself to this profile

Pulmatrix

Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Angel
$10,000,000
Venture capital (Series B)
$30,200,000
Employees

Team size

10+
Locations
HQ
Headquarters
$10,000,000 Angel
prnewswire

Pulmatrix Raises $10 Million Private Placement; To Begin Trading on NASDAQ under "PULM"

Xconomy

After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq

Health Strategy